Activity value 65International Buyer&Supplier,Last transaction date:
2025-02-18
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zoripharm international s.a. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 4 transactions, with a transaction quantity of 112321 and a transaction weight of 12577.49.
YearTransactionsQuantityWeight
202425219247568.5651827.6
2025411232112577.49
Bill of lading data
<
1/15
>
Trade date
2025/02/18
B/L No.
006-2025-028614
Suppliers
zoripharm international s.a.
Buyers
panamedical de costa rica s.a.
2marpel pharma s.a.
united statesbuyer,they trade on 2017-08-18
4412.12%
>
3amedex s.a.
costa ricabuyer,they trade on 2024-12-06
184.96%
>
Products
Total 5
ProductsTransactionsPerDetail
tablet 19475.78%>
medicament 5822.66%>
drug rofiprofen 20.78%>
trastuzumab 20.78%>
doxycycline 20.78%>
Hscode rank
Total 7
HSCode NameTransactionsPerDetail
HS 300490910019475.78%>
HS 30042010005722.27%>
HS 30042010000020.78%>
HS 30049091009020.78%>
HS 300490110010.39%>
Trading Area
Total 2
AreaTransactionsPerDetail
costa rica25670.52%>
united states4412.12%>
zoripharm international s.a. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet,medicament,drug rofiprofen.
According to the 52wmb.com global trade database, as of 2025-02-18, the company has completed 363 international trades,
with its main trading regions covering costa rica,united states etc.
The core products include HS3004909100,HS3004201000,HS300420100000 etc,
and its main trading partners are panamedical de costa rica s.a.,marpel pharma s.a.,amedex s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zoripharm international s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.